Health Policy
International
AMA PRA Category 1 Credits 1.25
CAMPEP Credits: 1.25
MDCB Credits: 1.25
May Abdel-Wahab, MD, PhD, FASTRO
International Atomic Energy Agency (IAEA)
Vienna, None, Austria
John Buatti, MD, FASTRO
University of Iowa Carver College of Medicine
Iowa City, Iowa
Smriti Patodia, PhD
The Lancet Oncology
London, England
The session will present initial findings of the Lancet Oncology Commission on Theranostics and Radiotherapy, first formally convened by the IAEA in 2021. The white paper highlights stark global disparities in relevant services and outlines a compelling health economics case for countries. Specifically, the findings illustrate that scaling up access to Radiotherapy and Theranostics for cancer patients would yield substantial health and economic benefits. This body of work builds upon prior Lancet Oncology commission reports for RT (2015) and medical imaging and nuclear medicine (2021). Ongoing research and pertinent initiatives will be showcased.
Speaker: May Abdel-Wahab, MD, PhD, FASTRO – International Atomic Energy Agency (IAEA)
Speaker: May Abdel-Wahab, MD, PhD, FASTRO – International Atomic Energy Agency (IAEA)
Speaker: Jean-Luc Urbain, MD, PhD, CPE, FASNC – Theranostic Solution
Speaker: Surbhi Grover, MD, MPH – University of Pennsylvania Health System
Speaker: Mauro Carrara, PhD
Speaker: Mary Gospodarowicz, MD, FASTRO – Princess Margaret Cancer Center
Speaker: John Buatti, MD, FASTRO – University of Iowa Carver College of Medicine